newsfilter
← Latest News
FDA Approved Drugs·

Approval of Zanvastro, Nda #220210 (Type 1 - New Molecular Entity)

Approval Date: 09/03/2026; Drug Name: Zanvastro, Nda #220210; Active Ingredients: ZILGANERSEN; Company: Ionis Pharms Inc; Submission Status: Approval; Submission Classification: Type 1 - New Molecular Entity; Application Number: 220210

Company
IONIS PHARMS INC
Keywords
IONIS PHARMS INC